Orthofix Medical (OFIX)
NASDAQ:OFIX
Want to see OFIX full AI Analyst Report?
OFIX Stock Chart & Stats
$12.39
-$0.08(-0.47%)
At close: 4:00 PM EST
$12.39
-$0.08(-0.47%)
Day’s Range― - ―
52-Week Range$10.24 - $16.99
Previous CloseN/A
Volume45.16K
Average Volume (3M)212.06K
Market Cap
$516.66M
Enterprise Value$644.63M
Total Cash (Recent Filing)$82.03M
Total Debt (Recent Filing)$229.26M
Price to Earnings (P/E)―
Beta1.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,144,398
10 Day Avg. Volume220,565
30 Day Avg. Volume212,061
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.34
Price to Sales (P/S)0.74
P/FCF Ratio-472.73
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit1.17
Enterprise Value/Ebitda7.65
Forecast
1Y Price Target
$18.33Price Target Upside47.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Leadership RealignmentSpine leaders reporting directly to the CEO and the limb reconstruction head assuming leadership of biologics should strengthen commercial execution and streamline product strategy.
Product Sales MomentumRobust demand for bone growth therapies lifted sales above expectations through higher utilization, faster prescribing by physicians, and effective cross-selling into related procedures.
Profitability And Cash GenerationConsecutive adjusted EBITDA margin expansion and notable free cash flow generation enhance financial flexibility and support a path to sustained, profitable growth.
Bears Say
Distribution Channel DisruptionOptimization of the spine distribution channel has created near-term sales pressure and delayed the timeline for predictable, scalable revenue from spine products.
Guidance And TargetsManagement lowering near-term guidance and pushing the long-range adjusted EBITDA margin target farther out signals more conservative growth assumptions and heightens execution uncertainty.
Valuation And Upgrade RiskDepressed valuation combined with an aggressive risk profile means the stock may remain under pressure until clear top-line acceleration convinces analysts to upgrade ratings.
Orthofix Medical News
OFIX FAQ
What was Orthofix Medical’s price range in the past 12 months?
Orthofix Medical lowest stock price was $10.24 and its highest was $16.99 in the past 12 months.
What is Orthofix Medical’s market cap?
Orthofix Medical’s market cap is $516.66M.
When is Orthofix Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Orthofix Medical’s earnings last quarter?
Currently, no data Available
Is Orthofix Medical overvalued?
According to Wall Street analysts Orthofix Medical’s price is currently Undervalued.
Does Orthofix Medical pay dividends?
Orthofix Medical does not currently pay dividends.
What is Orthofix Medical’s EPS estimate?
Orthofix Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orthofix Medical have?
Orthofix Medical has 40,144,398 shares outstanding.
What happened to Orthofix Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Orthofix Medical?
Currently, no hedge funds are holding shares in OFIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Orthofix Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.33 (47.94% Upside)
$18.33 (47.94% Upside)
Blogger Sentiment
Neutral
OFIX Sentiment 50%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.13%
12-Months-Change
Fundamentals
Return on Equity
-20.38%
Trailing 12-Months
Asset Growth
-4.77%
Trailing 12-Months
Company Description
Orthofix Medical
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
OFIX Company Deck
OFIX Earnings Call
Q4 2026
0:00 / 0:00
OFIX Stock 12 Month Forecast
Average Price Target
$18.33
▲(47.94% Upside)
Technical Analysis
Ownership Overview
14.32% Insiders
12.57% Mutual Funds
50.79% Other Institutional Investors
10.18% Public Companies and
Individual Investors